{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T19:55:40Z","timestamp":1774641340468,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Valneva, Austria, GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Chikungunya virus (CHIKV) is a mosquito-transmitted, arthritogenic alphavirus that causes sporadic outbreaks of often debilitating rheumatic disease. The recently approved CHIKV vaccine, IXCHIQ, is based on a live-attenuated CHIKV strain (VLA1553), with viraemic vaccine recipients theoretically able to transmit VLA1553 to mosquitoes with ensuing onward transmission. We thus evaluated VLA1553 transmission from artificial blood meals to <jats:italic>Aedes albopictus<\/jats:italic> mosquitoes, and onward transmission to mice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Female <jats:italic>A. albopictus<\/jats:italic> mosquitoes were fed on defibrinated sheep blood containing wild-type CHIKV (viral titre: 7.50 log<jats:sub>10<\/jats:sub>CCID<jats:sub>50<\/jats:sub>\/mL) or VLA1553 (viral titres: 7.85, 5.72, 4.58, and 3.79 log<jats:sub>10<\/jats:sub>CCID<jats:sub>50<\/jats:sub>\/mL). Viral titres in mosquito bodies and saliva were determined using CCID<jats:sub>50<\/jats:sub> assays 7\u20138\u00a0days after the blood meal. After providing CHIKV or VLA1553 (viral titres\u2009~\u20097\u20138 log<jats:sub>10<\/jats:sub>CCID<jats:sub>50<\/jats:sub>\/mL) in blood meals to mosquitoes, infected mosquitoes were fed on highly susceptible <jats:italic>Irf3\/7<\/jats:italic>\n              <jats:sup>\u2212\/\u2212<\/jats:sup> mice (<jats:italic>n<\/jats:italic>\u2009=\u20093 per group). Data were re-analysed using the same reverse transcription quantitative polymerase chain reaction (RT-qPCR) as for an earlier VLA1553 phase 1 clinical trial, to allow correlations between blood meal titres and viraemia in vaccine recipients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Mosquito body viral titres were significantly higher (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) for CHIKV versus VLA1553-fed mosquitoes at blood meal viral titres of\u2009~\u20097\u20138 log<jats:sub>10<\/jats:sub>CCID<jats:sub>50<\/jats:sub>\/mL. Mosquito body VLA1553 titres decreased with reducing blood meal titres, but there was no dose-dependent effect on saliva viral titres. No dissemination to salivary glands was seen at blood meal titres\u2009\u2264\u20093.875 log<jats:sub>10<\/jats:sub>CCID<jats:sub>50<\/jats:sub>\/mL. CHIKV-fed mosquitoes were able to transmit virus, and induce viraemia in, 3\/3 <jats:italic>Irf3\/7<\/jats:italic>\n              <jats:sup>\u2212\/\u2212<\/jats:sup> mice via mosquito bites. In contrast, 0\/3 <jats:italic>Irf3\/7<\/jats:italic>\n              <jats:sup>\u2212\/\u2212<\/jats:sup> mice became infected after bites from VLA1553-fed mosquitoes. RT-qPCR comparisons with phase 1 clinical data for VLA1553-vaccinated individuals indicated that VLA1553 viraemia was at or below the aforementioned threshold for transmission.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The evidence presented herein argue that the low viraemia in VLA1553-vaccinated individuals would mitigate against transmission. In addition, replication of VLA1553 in mosquito bodies was also significantly attenuated. Overall, mosquito-borne transmission of VLA1553 from vaccinated individuals to others appears improbable.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s13071-025-06789-w","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T16:02:14Z","timestamp":1747065734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Assessment of the transmission of live-attenuated chikungunya virus vaccine VLA1553 by Aedes albopictus mosquitoes"],"prefix":"10.1186","volume":"18","author":[{"given":"Andrea","family":"Fritzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Suhrbier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon E.","family":"Hugo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Devine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Jost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas L.","family":"Meinke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"6789_CR1","doi-asserted-by":"crossref","unstructured":"Wimalasiri-Yapa BMCR, Barrero RA, Stassen L, Hafner LM, McGraw EA, Pyke AT, et al. Temperature modulates immune gene expression in mosquitoes during arbovirus infection. Open Biol. 2021;11:200246. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33401993.","DOI":"10.1098\/rsob.200246"},{"key":"6789_CR2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41584-019-0276-9","volume":"15","author":"A Suhrbier","year":"2019","unstructured":"Suhrbier A. Rheumatic manifestations of chikungunya: emerging concepts and interventions. Nat Rev Rheumatol. 2019;15:597\u2013611. https:\/\/doi.org\/10.1038\/s41584-019-0276-9.","journal-title":"Nat Rev Rheumatol"},{"key":"6789_CR3","doi-asserted-by":"publisher","unstructured":". Hou W, Zhou Y, Luo W, Wang L, Kwan M-P, Cook AR. Mapping environmental suitability changes for arbovirus mosquitoes in Southeast Asia: 1960\u20132020. Iscience. 2024;27:110498. https:\/\/doi.org\/10.1016\/j.isci.2024.110498.","DOI":"10.1016\/j.isci.2024.110498"},{"key":"6789_CR4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41577-024-01016-6","volume":"24","author":"DJ Rawle","year":"2024","unstructured":"Rawle DJ, Hugo LE, Cox AL, Devine GJ, Suhrbier A. Generating prophylactic immunity against arboviruses in vertebrates and invertebrates. Nat Rev Immunol. 2024;24:621\u201336. https:\/\/doi.org\/10.1038\/s41577-024-01016-6.","journal-title":"Nat Rev Immunol"},{"key":"6789_CR5","doi-asserted-by":"crossref","unstructured":"Rezza G, Weaver SC. Chikungunya as a paradigm for emerging viral diseases: valuating disease impact and hurdles to vaccine development. PLoS Negl Trop Dis. 2019;13:e0006919. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30653504.","DOI":"10.1371\/journal.pntd.0006919"},{"key":"6789_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-med-050715-105122","volume":"69","author":"SC Weaver","year":"2018","unstructured":"Weaver SC, Charlier C, Vasilakis N, Lecuit M. Zika, chikungunya, and other emerging vector-borne viral diseases. Annu Rev Med. 2018;69:395\u2013408. https:\/\/doi.org\/10.1146\/annurev-med-050715-105122.","journal-title":"Annu Rev Med"},{"key":"6789_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nrrheum.2012.64","volume":"8","author":"A Suhrbier","year":"2012","unstructured":"Suhrbier A, Jaffar-Bandjee MC, Gasque P. Arthritogenic alphaviruses\u2013an overview. Nat Rev Rheumatol. 2012;8:420\u20139. https:\/\/doi.org\/10.1038\/nrrheum.2012.64.","journal-title":"Nat Rev Rheumatol"},{"key":"6789_CR8","unstructured":"Chikungunya worldwide overview. European Centre for Disease Prevention and Control. https:\/\/www.ecdc.europa.eu\/en\/chikungunya-monthly. Accessed Sep 2024."},{"key":"6789_CR9","first-page":"1","volume":"2024","author":"MF de Neri","year":"2018","unstructured":"de Neri MF, Draper AD, Fernandes AM, Dos Santos FBA, Mali MA, Tilman AJP, et al. The first confirmed outbreak of chikungunya reported in Timor-Leste, 2024. Commun Dis Intell. 2018;2024:1\u20139.","journal-title":"Commun Dis Intell"},{"key":"6789_CR10","doi-asserted-by":"publisher","unstructured":"Cerqueira-Silva T, Pescarini JM, Cardim LL, Leyrat C, Whitaker H, Antunes de Brito CA, et al. Risk of death following chikungunya virus disease in the 100 Million Brazilian Cohort, 2015\u201318: a matched cohort study and selfcontrolled case series. Lancet Infect Dis. 2024;24:504-513. https:\/\/doi.org\/10.1016\/S1473-3099(23)00739-9.","DOI":"10.1016\/S1473-3099(23)00739-9"},{"key":"6789_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/trstmh\/try063","volume":"112","author":"ES Paixao","year":"2018","unstructured":"Paixao ES, Rodrigues LC, Costa M, Itaparica M, Barreto F, Gerardin P, et al. Chikungunya chronic disease: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg. 2018;112:301\u201316. https:\/\/doi.org\/10.1093\/trstmh\/try063.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"6789_CR12","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1017\/S0950268811001300","volume":"140","author":"A Chopra","year":"2012","unstructured":"Chopra A, Anuradha V, Ghorpade R, Saluja M. Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol Infect. 2012;140:842\u201350. https:\/\/doi.org\/10.1017\/S0950268811001300.","journal-title":"Epidemiol Infect"},{"key":"6789_CR13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.5694\/j.1326-5377.2002.tb04837.x","volume":"177","author":"AD Mylonas","year":"2002","unstructured":"Mylonas AD, Brown AM, Carthew TL, McGrath B, Purdie DM, Pandeya N, et al. Natural history of Ross River virus-induced epidemic polyarthritis. Med J Aust. 2002;177:356\u201360. https:\/\/doi.org\/10.5694\/j.1326-5377.2002.tb04837.x.","journal-title":"Med J Aust"},{"key":"6789_CR14","doi-asserted-by":"crossref","unstructured":"Puntasecca CJ, King CH, LaBeaud AD. Measuring the global burden of chikungunya and Zika viruses: A systematic review. PLoS Negl Trop Dis. 2021;15:e0009055. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33661908.","DOI":"10.1371\/journal.pntd.0009055"},{"key":"6789_CR15","doi-asserted-by":"publisher","unstructured":"Roiz D, Pontifes PA, Jourdain F, Diagne C, Leroy B, Vaissi\u00e8re A-C, et al. The rising global economic costs of invasive Aedes mosquitoes and Aedesborne diseases. Sci Total Environ. 2024 ;933:173054. https:\/\/doi.org\/10.1016\/j.scitotenv.2024.173054.","DOI":"10.1016\/j.scitotenv.2024.173054"},{"key":"6789_CR16","doi-asserted-by":"crossref","unstructured":"de Roo AM, Vondeling GT, Boer M, Murray K, Postma MJ. The global health and economic burden of chikungunya from 2011 to 2020: a modeldriven analysis on the impact of an emerging vector-borne disease. BMJ Glob Health. 2024;9:e016648. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/39627007.","DOI":"10.1136\/bmjgh-2024-016648"},{"key":"6789_CR17","doi-asserted-by":"crossref","unstructured":"Amaral JK, Lucena G, Schoen RT. Chikungunya arthritis treatment with methotrexate and dexamethasone: a randomized, double-blind placebo-controlled trial. Curr Rheumatol Rev. 2024;20:337\u2013346. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38173199.","DOI":"10.2174\/0115733971278715231208114037"},{"key":"6789_CR18","doi-asserted-by":"publisher","unstructured":"Chen LH, Fritzer A, Hochreiter R, Dubischar K, Meyer S. From bench to clinic: the development of VLA1553\/IXCHIQ, a live-attenuated chikungunya vaccine. J Travel Med. 2024;31:taae123. https:\/\/doi.org\/10.1093\/jtm\/taae123.10.1093\/jtm\/taae123.","DOI":"10.1093\/jtm\/taae123.10.1093\/jtm\/taae123"},{"key":"6789_CR19","doi-asserted-by":"crossref","unstructured":"Roques P, Fritzer A, Dereuddre-Bosquet N, Wressnigg N, Hochreiter R, Bossevot L, et al. Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera. JCI Insight. 2022;7:e160173. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35700051.","DOI":"10.1172\/jci.insight.160173"},{"key":"6789_CR20","doi-asserted-by":"crossref","unstructured":"Roques P, Ljungberg K, Kummerer BM, Gosse L, Dereuddre-Bosquet N, Tchitchek N, et al. Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus. JCI Insight. 2017;2:e83527. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28352649.","DOI":"10.1172\/jci.insight.83527"},{"key":"6789_CR21","doi-asserted-by":"crossref","unstructured":"Buerger V, Maurer G, Kosulin K, Hochreiter R, Larcher-Senn J, Dubischar K, et al. Combined immunogenicity evaluation for a new single-dose live-attenuated chikungunya vaccine. J Travel Med. 2024;31:taae084. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38959854.","DOI":"10.1093\/jtm\/taae084"},{"key":"6789_CR22","doi-asserted-by":"crossref","unstructured":"McMahon R, Fuchs U, Schneider M, Hadl S, Hochreiter R, Bitzer A, et al. A randomized, double-blinded phase 3 study to demonstrate lot-to-lot consistency and to confirm immunogenicity and safety of the liveattenuated chikungunya virus vaccine candidate VLA1553 in healthy adults. J Travel Med. 2023;31:taad156. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38091981.","DOI":"10.1093\/jtm\/taad156"},{"key":"6789_CR23","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/S1473-3099(24)00357-8","volume":"24","author":"R McMahon","year":"2024","unstructured":"McMahon R, Toepfer S, Sattler N, Schneider M, Narciso-Abraham M, Hadl S, et al. Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b study. Lancet Infect Dis. 2024;24:1383\u201392.","journal-title":"Lancet Infect Dis"},{"key":"6789_CR24","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/S0140-6736(23)00641-4","volume":"401","author":"M Schneider","year":"2023","unstructured":"Schneider M, Narciso M, Hadl S, McMahon R, T\u00f6pfer S, Fuchs U, et al. Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicenter, randomized, placebo-controlled phase 3 trial. Lancet. 2023;401:2138\u201347.","journal-title":"Lancet"},{"key":"6789_CR25","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S1473-3099(20)30238-3","volume":"20","author":"N Wressnigg","year":"2020","unstructured":"Wressnigg N, Hochreiter R, Zoihsl O, Fritzer A, Bezay N, Klingler A, et al. Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial. Lancet Infect Dis. 2020;20:1193\u2013203. https:\/\/doi.org\/10.1016\/S1473-3099(20)30238-3.","journal-title":"Lancet Infect Dis"},{"key":"6789_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S1473-3099(24)00458-4","volume":"25","author":"V Buerger","year":"2024","unstructured":"Buerger V, Hadl S, Schneider M, Schaden M, Hochreiter R, Bitzer A, et al. Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in endemic areas of Brazil: interim results of a double-blind, randomised, placebo-controlled phase 3 trial in adolescents. Lancet Infect Dis. 2024;25:114\u201325. https:\/\/doi.org\/10.1016\/S1473-3099(24)00458-4.","journal-title":"Lancet Infect Dis"},{"key":"6789_CR27","unstructured":"FDA: IXCHIQ (Chikungunya Vaccine, Live) Solution for Intramuscular Injection. https:\/\/www.fda.gov\/files\/vaccines%2C%20blood%20%26%20biologics\/published\/Package-Insert-IXCHIQ.pdf. 2023."},{"key":"6789_CR28","unstructured":"Valneva: Valneva Announces Health Canada Approval of World\u2019s First Chikungunya Vaccine, IXCHIQ\u00ae. https:\/\/valneva.com\/press-release\/valneva-announces-health-canada-approval-of-the-worlds-first-chikungunya-vaccine-ixchiq\/ 2024."},{"key":"6789_CR29","unstructured":"Valneva: Valneva Receives Marketing Authorization in Europe for the World\u2019s First Chikungunya Vaccine, IXCHIQ\u00ae. https:\/\/valneva.com\/press-release\/valneva-receives-marketing-authorization-in-europe-for-the-worlds-first-chikungunya-vaccine-ixchiq\/ 2024."},{"key":"6789_CR30","doi-asserted-by":"publisher","unstructured":". Bellone R, Mousson L, Bohers C, Mantel N, Failloux A-B. Absence of transmission of vYF next generation Yellow Fever vaccine in mosquitoes. PLOS Negl Trop Dis. 2022 ;16:e0010930. https:\/\/doi.org\/10.1371\/journal.pntd.0010930.","DOI":"10.1371\/journal.pntd.0010930"},{"key":"6789_CR31","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/oxfordjournals.aje.a121416","volume":"95","author":"CE Pedersen Jr","year":"1972","unstructured":"Pedersen CE Jr, Robinson DM, Cole FE Jr. Isolation of the vaccine strain of Venezuelan equine encephalomyelitis virus from mosquitoes in Louisiana. Am J Epidemiol. 1972;95:490\u20136. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a121416.","journal-title":"Am J Epidemiol"},{"key":"6789_CR32","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.3390\/v7072795","volume":"7","author":"AW Franz","year":"2015","unstructured":"Franz AW, Kantor AM, Passarelli AL, Clem RJ. Tissue barriers to arbovirus infection in mosquitoes. Viruses. 2015;7:3741\u201367. https:\/\/doi.org\/10.3390\/v7072795.","journal-title":"Viruses"},{"key":"6789_CR33","doi-asserted-by":"crossref","unstructured":"Hugo LE, Prow NA, Tang B, Devine G, Suhrbier A. Chikungunya virus transmission between Aedes albopictus and laboratory mice. Parasit Vectors. 2016;9:555. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27760560.","DOI":"10.1186\/s13071-016-1838-1"},{"key":"6789_CR34","doi-asserted-by":"crossref","unstructured":"Carpenter A, Clem RJ. Factors affecting arbovirus midgut escape in mosquitoes. Pathogens. 2023;12:220.","DOI":"10.3390\/pathogens12020220"},{"key":"6789_CR35","doi-asserted-by":"crossref","unstructured":"Sanchez-Vargas I, Olson KE, Black WC. The genetic basis for salivary gland\nbarriers to arboviral transmission. Insects. 2021;12:73\n.","DOI":"10.3390\/insects12010073"},{"key":"6789_CR36","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1603\/033.046.0228","volume":"46","author":"K Pesko","year":"2009","unstructured":"Pesko K, Westbrook CJ, Mores CN, Lounibos LP, Reiskind MH. Effects of infectious virus dose and bloodmeal delivery method on susceptibility of Aedes aegypti and Aedes albopictus to chikungunya virus. J Med Entomol. 2009;46:395\u20139. https:\/\/doi.org\/10.1603\/033.046.0228.","journal-title":"J Med Entomol"},{"key":"6789_CR37","doi-asserted-by":"crossref","unstructured":"Ledermann JP, Borland EM, Powers AM. Minimum infectious dose for chikungunya virus in Aedes aegypti and Ae. albopictus mosquitoes. Rev Panam Salud Publica. 2017;41:e65. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28902278.","DOI":"10.26633\/RPSP.2017.65"},{"key":"6789_CR38","doi-asserted-by":"publisher","first-page":"14688","DOI":"10.1073\/pnas.1508114112","volume":"112","author":"V Duong","year":"2015","unstructured":"Duong V, Lambrechts L, Paul RE, Ly S, Lay RS, Long KC, et al. Asymptomatic humans transmit dengue virus to mosquitoes. Proc Natl Acad Sci U S A. 2015;112:14688\u201393. https:\/\/doi.org\/10.1073\/pnas.1508114112.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6789_CR39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1073\/pnas.1715788115","volume":"115","author":"LB Carrington","year":"2018","unstructured":"Carrington LB, Tran BCN, Le NTH, Luong TTH, Nguyen TT, Nguyen PT, et al. Field- and clinically derived estimates of Wolbachia-mediated blocking of dengue virus transmission potential in Aedes aegypti mosquitoes. Proc Natl Acad Sci U S A. 2018;115:361\u20136. https:\/\/doi.org\/10.1073\/pnas.1715788115.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6789_CR40","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1172\/JCI40104","volume":"120","author":"K Labadie","year":"2010","unstructured":"Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P, et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest. 2010;120:894\u2013906. https:\/\/doi.org\/10.1172\/JCI40104.","journal-title":"J Clin Invest"},{"key":"6789_CR41","doi-asserted-by":"crossref","unstructured":"Sanchez-Vargas I, Harrington LC, Black WC, Olson KE. Analysis of salivary glands and saliva from Aedes albopictus and Aedes aegypti infected with chikungunya viruses. Insects. 2019;10:39.","DOI":"10.3390\/insects10020039"},{"key":"6789_CR42","doi-asserted-by":"publisher","unstructured":"Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLOS Pathog. 2007;3:e201. https:\/\/doi.org\/10.1371\/journal.ppat.0030201.","DOI":"10.1371\/journal.ppat.0030201"},{"key":"6789_CR43","doi-asserted-by":"publisher","first-page":"9888","DOI":"10.1128\/JVI.00956-12","volume":"86","author":"PA Rudd","year":"2012","unstructured":"Rudd PA, Wilson J, Gardner J, Larcher T, Babarit C, Le TT, et al. Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock. J Virol. 2012;86:9888\u201398. https:\/\/doi.org\/10.1128\/JVI.00956-12.","journal-title":"J Virol"},{"key":"6789_CR44","doi-asserted-by":"publisher","unstructured":"Rama K, de Roo AM, Louwsma T, Hofstra HS, Gurgel do Amaral GS, Vondeling GT, et al. Clinical outcomes of chikungunya: a systematic literature review and meta-analysis. PLOS Negl Trop Dis. 2024 ;18:e0012254. https:\/\/doi.org\/10.1371\/journal.pntd.0012254.","DOI":"10.1371\/journal.pntd.0012254"},{"key":"6789_CR45","doi-asserted-by":"crossref","unstructured":"Yan K, Dumenil T, Tang B, Le TT, Bishop CR, Suhrbier A, et al. Evolution of ACE2-independent SARS-CoV-2 infection and mouse adaption after passage in cells expressing human and mouse ACE2. Virus Evol. 2022;8:veac063. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35919871.","DOI":"10.1093\/ve\/veac063"},{"key":"6789_CR46","doi-asserted-by":"crossref","unstructured":"Poo YS, Rudd PA, Gardner J, Wilson JA, Larcher T, Colle MA, et al. Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection. PLoS Negl Trop Dis. 2014 ;8:e3354. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25474568.","DOI":"10.1371\/journal.pntd.0003354"},{"key":"6789_CR47","doi-asserted-by":"publisher","first-page":"8021","DOI":"10.1128\/JVI.02603-09","volume":"84","author":"J Gardner","year":"2010","unstructured":"Gardner J, Anraku I, Le TT, Larcher T, Major L, Roques P, et al. Chikungunya virus arthritis in adult wild-type mice. J Virol. 2010;84:8021\u201332. https:\/\/doi.org\/10.1128\/JVI.02603-09.","journal-title":"J Virol"},{"key":"6789_CR48","doi-asserted-by":"crossref","unstructured":"Dubrulle M, Mousson L, Moutailler S, Vazeille M, Failloux AB. Chikungunya virus and Aedes mosquitoes: saliva is infectious as soon as two days after oral infection. PLoS One. 2009;4:e5895. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19521520.","DOI":"10.1371\/journal.pone.0005895"},{"key":"6789_CR49","doi-asserted-by":"crossref","unstructured":"Poole-Smith BK, Hemme RR, Delorey M, Felix G, Gonzalez AL, Amador M, et al. Comparison of vector competence of Aedes mediovittatus and Aedes aegypti for dengue virus: implications for dengue control in the Caribbean. PLoS Negl Trop Dis. 2015;9:e0003462. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25658951.","DOI":"10.1371\/journal.pntd.0003462"},{"key":"6789_CR50","doi-asserted-by":"crossref","unstructured":"Ye YH, Carrasco AM, Frentiu FD, Chenoweth SF, Beebe NW, van den Hurk AF, et al. Wolbachia reduces the transmission potential of dengue-infected Aedes aegypti. PLoS Negl Trop Dis. 2015;9:e0003894. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26115104.","DOI":"10.1371\/journal.pntd.0003894"},{"key":"6789_CR51","unstructured":"TCID50 calculator (v2.1). https:\/\/view.officeapps.live.com\/op\/view.aspx?src=https%3A%2F%2Fwww.klinikum.uni-heidelberg.de%2Ffileadmin%2Finst_hygiene%2Fmolekulare_virologie%2FDownloads%2FTCID50_calculator_v2_17-01-20_MB.xlsx&wdOrigin=BROWSELINK (2017)."},{"key":"6789_CR52","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3201\/eid1403.070906","volume":"14","author":"M Panning","year":"2008","unstructured":"Panning M, Grywna K, van Esbroeck M, Emmerich P, Drosten C. Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006. Emerg Infect Dis. 2008;14:416\u201322. https:\/\/doi.org\/10.3201\/eid1403.070906.","journal-title":"Emerg Infect Dis"},{"key":"6789_CR53","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41586-024-07848-5","volume":"633","author":"A Chandel","year":"2024","unstructured":"Chandel A, DeBeaubien NA, Ganguly A, Meyerhof GT, Krumholz AA, Liu J, et al. Thermal infrared directs host-seeking behaviour in Aedes aegypti mosquitoes. Nature. 2024;633:615\u201323. https:\/\/doi.org\/10.1038\/s41586-024-07848-5.doi:10.1038\/s41586-024-07848-5.","journal-title":"Nature"},{"key":"6789_CR54","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1016\/j.cell.2022.05.016","volume":"185","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zhu Y, Liu Z, Peng Y, Peng W, Tong L, et al. A volatile from the skin microbiota of flavivirus-infected hosts promotes mosquito attractiveness. Cell. 2022;185:2510\u201322. https:\/\/doi.org\/10.1016\/j.cell.2022.05.016.","journal-title":"Cell"},{"key":"6789_CR55","doi-asserted-by":"publisher","unstructured":"Armstrong PM, Ehrlich HY, Magalhaes T, Miller MR, Conway PJ, Bransfield A, et al. Successive blood meals enhance virus dissemination within mosquitoes and increase transmission potential. Nat Microbiol. 2020;5:239\u201347. https:\/\/doi.org\/10.1038\/s41564-019-0619-y.doi:10.1038\/s41564-019-0619-y.","DOI":"10.1038\/s41564-019-0619-y.doi:10.1038\/s41564-019-0619-y"},{"key":"6789_CR56","doi-asserted-by":"crossref","unstructured":"Zakrzewski M, Rasic G, Darbro J, Krause L, Poo YS, Filipovic I, et al. Mapping the virome in wild-caught Aedes aegypti from Cairns and Bangkok. Sci Rep. 2018;8:4690. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29549363.","DOI":"10.1038\/s41598-018-22945-y"},{"key":"6789_CR57","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1089\/vbz.2009.0026","volume":"10","author":"H Delatte","year":"2010","unstructured":"Delatte H, Desvars A, Bouetard A, Bord S, Gimonneau G, Vourc\u2019h G, et al. Blood-feeding behavior of Aedes albopictus, a vector of chikungunya on La Reunion. Vector Borne Zoonotic Dis. 2010;10:249\u201358. https:\/\/doi.org\/10.1089\/vbz.2009.0026.","journal-title":"Vector Borne Zoonotic Dis"},{"key":"6789_CR58","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1603\/me12146","volume":"50","author":"T Farjana","year":"2013","unstructured":"Farjana T, Tuno N. Multiple blood feeding and host-seeking behavior in Aedes aegypti and Aedes albopictus (Diptera: Culicidae). J Med Entomol. 2013;50:838\u201346. https:\/\/doi.org\/10.1603\/me12146.","journal-title":"J Med Entomol."},{"key":"6789_CR59","doi-asserted-by":"publisher","first-page":"827","DOI":"10.4269\/ajtmh.1978.27.827","volume":"27","author":"MJ Klowden","year":"1978","unstructured":"Klowden MJ, Lea AO. Blood meal size as a factor affecting continued host-seeking by Aedes aegypti (L.). Am J Trop Med Hyg. 1978;27:827\u201331. https:\/\/doi.org\/10.4269\/ajtmh.1978.27.827.","journal-title":"Am J Trop Med Hyg"},{"key":"6789_CR60","doi-asserted-by":"crossref","unstructured":"Vallejo AF, Rubiano K, Amado A, Krystosik AR, Herrera S, Arevalo-Herrera M. Optimization of a membrane feeding assay for Plasmodium vivax infection in Anopheles albimanus. PLoS Negl Trop Dis. 2016;10:e0004807. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27355210.","DOI":"10.1371\/journal.pntd.0004807"},{"key":"6789_CR61","doi-asserted-by":"crossref","unstructured":"Mukherjee D, Das S, Begum F, Mal S, Ray U. The mosquito immune system and the life of dengue virus: what we know and do not know. Pathogens. 2019;8:77. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31200426.","DOI":"10.3390\/pathogens8020077"},{"key":"6789_CR62","doi-asserted-by":"crossref","unstructured":"Tan CH, Wong PS, Li MZ, Yang HT, Chong CS, Lee LK, et al. Membrane feeding of dengue patient's blood as a substitute for direct skin feeding in studying Aedes-dengue virus interaction. Parasit Vectors. 2016;9:211. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27083158.","DOI":"10.1186\/s13071-016-1469-6"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06789-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-06789-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06789-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T16:02:21Z","timestamp":1747065741000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-025-06789-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6789"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-06789-w","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The mouse studies were undertaken in accordance with the Australian Code for the Care and Use of Animals for Scientific Purposes as defined by the National Health and Medical Research Council of Australia, approved by the QIMR Berghofer Medical Research Institute animal ethics committee. Consent for participation was not applicable since no human participants were included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable as no human participants were included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.F., S.J. and A.M. are employees of Valneva Austria GmbH and own stock and share options in Valneva. Mosquito transmission and mouse studies were undertaken at QIMR Berghofer MRI by A.S., L.H., B.T. and G.D., funded by collaborative R&D contracts from Valneva.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}